Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis (Editorials) Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis (Editorials)

Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis (Editorials‪)‬

Clinical Chemistry, 2005, August, 51, 8

    • €2.99
    • €2.99

Publisher Description

Two reports in this issue of Clinical Chemistry describe novel mutations in thrombophilia genes (1, 2). The authors of the reports describe variants detected by the identification of a melting temperature ([T.sub.m]) different from the expected [T.sub.m] of the target mutation and from the [T.sub.m] of the wild-type sequence. The variants reported in this issue are A20218G in the prothrombin (factor II) gene and C1690T in the factor V gene. These cases add to the reported variants identified by fluorescent hybridization probes and melting analysis on the LightCycler. In addition to factor II and V variants, variants have been discovered similarly in genes coding for MTHFR and HFE (3, 4). Melting analyses, as performed on the LightCycler or similar instruments, can distinguish variants that lie within the region of the target probe. Differences in base composition, nucleotide position, and nearest-neighbor environments all affect [T.sub.m]. These differences are detected by monitoring fluorescence during an increase in temperature. Melting is visualized by a loss of fluorescence as the probes dissociate from the template. Differences in [T.sub.m] from the expected [T.sub.m] for wild-type and target mutations are indicative of a nontarget (a variant other than the mutation the assay was designed to detect) mutation or variant.

GENRE
Science & Nature
RELEASED
2005
1 August
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
176.4
KB
Selected Exonic Sequencing of the AGXT Gene Provides a Genetic Diagnosis in 50% of Patients with Primary Hyperoxaluria Type I (Molecular Diagnostics and Genetics) Selected Exonic Sequencing of the AGXT Gene Provides a Genetic Diagnosis in 50% of Patients with Primary Hyperoxaluria Type I (Molecular Diagnostics and Genetics)
2007
Does Phaster Mean Better?(Editorial) Does Phaster Mean Better?(Editorial)
1997
Methods for Detection of Point Mutations: Performance and Quality Assessment. Methods for Detection of Point Mutations: Performance and Quality Assessment.
1997
Chemical Diagnostics Chemical Diagnostics
2013
Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Comparative Genomics Comparative Genomics
2014
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003